The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
about
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesMethods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients.Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.A novel dried blood spot-LCMS method for the quantification of methotrexate polyglutamates as a potential marker for methotrexate use in children.Autoimmune neuromuscular disorders in childhoodThe heterogeneity of juvenile myositisJuvenile dermatomyositis: new insights and new treatment strategies.Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study.Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?Recurrence of juvenile dermatomyositis 8 years after remission.Consensus-based recommendations for the management of juvenile dermatomyositis.Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.Therapies for multiple sclerosis: considerations in the pediatric patient.Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.Management of cutaneous dermatomyositis.Clinical features and disease course of patients with juvenile dermatomyositis.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.Treatment of Juvenile Dermatomyositis: An Update.Cardiac findings in children with juvenile Dermatomyositis at disease presentation.Anti-Jo-1 antibody positive polymyositis--successful therapy with leflunomide.Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis.Transdermal delivery of methotrexate for pediatrics using silicon microneedles.Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system.[Myositides: What is the current situation?].Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO studyMultinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t
P2860
Q26863125-91C4E71F-8CBE-443F-9240-9A5A6985515BQ30235042-6B72CE5B-2B2C-42C4-9B38-067109F57F18Q33556620-777A1BD9-4AA1-4FC7-A734-24C763275512Q33694683-9955157E-E4C2-40A3-A447-803F96657257Q33795594-C59F4EA3-6E90-45F4-BCE7-5D1126407270Q34124740-D323C9AD-25C2-4F6D-AB35-668D313A8F97Q34349952-AB591136-2A6B-4A89-AD24-3F95E6CEAA9DQ34626240-6E3BD8A2-0CF0-4FFC-A63C-D2FCBE75CB3EQ35009335-74E67A1A-0CF0-45EC-99F5-D71D7FE06195Q35108331-078536D6-D8BF-4661-BA8D-E497F683890DQ35512273-557F907E-F568-4768-8448-5F94892083B7Q35748264-D9FA61CE-BB61-4AFF-A31A-D269103C5BE8Q36059542-493A80A9-87A5-412E-AEE4-5588B1153492Q36498667-BDB50C86-CE77-4F09-98F6-182406B34881Q36903076-60101B9E-546B-4DB3-A700-A4795442A3EFQ37539217-40BF283F-F007-49AD-A623-3E61BF5135E9Q37617000-001C815F-3FFD-451F-8405-C1C461AC45EBQ37789530-D433FB74-3A8A-46B2-8272-B8317FBF8662Q37827690-DC2156BD-C919-4FC3-ACCE-BAA509F242B1Q37938701-87DEEB41-FD0E-4A4C-B0E1-AF8DB425D582Q38022271-D08A3865-0C69-4ADB-B493-8A8874CBEC24Q38155955-EC523667-CF89-47F4-BBC2-5D4382919139Q38221095-86781957-B330-476E-9A39-EBBFBC305C41Q38597575-2F5F0242-6E33-4587-A794-3DFFC80C9A94Q38664251-39D3D6C9-E45D-46C5-B62F-554184E4ACB8Q38678257-677917BD-5F4A-44DE-B138-EF5357488D37Q39426129-431A750F-205D-4C97-8F97-6C9CD62CE6AFQ40476936-E73F897C-41D2-4DEA-8993-EFA7E339C1F7Q40479791-EB50150E-F4E1-43DD-B8E7-95BD6DDB51D9Q41921482-3844DC47-3313-408E-A881-B5585C4C043EQ42363358-DC9E38F4-D66A-4DA7-8CF9-4CA7F5368BD8Q42632915-C788D8F6-78F7-4074-819C-B06AB1810666Q43633796-91858723-91F1-4EE0-A6B5-EA1901E28378Q50234928-12CE970F-1FF8-47B6-8EF0-1A4A097AF2DCQ53089650-D43A9075-3FFD-4F91-93D1-A023BB019AB8Q54258621-E7EB1720-FE4B-4E5E-B1C6-45E6221DD5EFQ56966414-89667468-8706-4DC6-8614-E98BD9EA9D7DQ56966479-24662E0A-CCF9-4EF9-9FC2-2961460D9A55
P2860
The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The effectiveness of treating ...... ively tapered corticosteroids.
@en
The effectiveness of treating ...... ively tapered corticosteroids.
@nl
type
label
The effectiveness of treating ...... ively tapered corticosteroids.
@en
The effectiveness of treating ...... ively tapered corticosteroids.
@nl
prefLabel
The effectiveness of treating ...... ively tapered corticosteroids.
@en
The effectiveness of treating ...... ively tapered corticosteroids.
@nl
P2093
P356
P1476
The effectiveness of treating ...... ively tapered corticosteroids.
@en
P2093
Campbell-Webster N
Feldman BM
Ramanan AV
Schneider R
Silverman ED
P304
P356
10.1002/ART.21378
P577
2005-11-01T00:00:00Z